Recently, several cases of adult T-cell leukemia (ATL) with CD30 antig
en have been reported, but its clinical significance remains unknown.
Accordingly, we studied CD30 antigen expression in ATL cases and docum
ented the clinicopathological characteristics of these cases. Immunohi
stochemical and clinical characteristics were studied in 46 patients w
ith malignant lymphoma or benign lesions of lymphoid tissue, who had a
ntibodies against human T-cell leukemia virus type I (HTLV-I). Monoclo
nal integration of HTLV-I provirus was demonstrated in the tumor cells
in 36 (ATL) of the 46 cases. CD30 antigen expression was evident in s
even of these 36 cases (19.4%), however it was not seen in any of the
ten cases lacking the integration of HTLV-I provirus. A comparison of
ATL cases with and without CD30 antigen expression revealed significan
tly larger numbers of abnormal lymphocytes in the peripheral blood and
lower serum calcium levels in ATL expressing CD30 antigen.